5-Nitroisatoic anhydride is a pharmaceutical intermediate used in the synthesis of the muscle relaxant flupirtine. Flupirtine, first launched in Japan in 1983 and developed by Tanabe Seiyaku Co., Ltd., has demonstrated excellent efficacy in treating facial and cervical muscle spasms after more than two decades of clinical use.